Organization
Amckaus
2 clinical trials
1 abstract
Clinical trial
Single-center, Randomised, Double-blind, Placebo-controlled Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetic Profile of Single- and Multiple-dose Ascending Oral QG101-23-0 Capsules in Healthy SubjectsStatus: Recruiting, Estimated PCD: 2024-02-01
Clinical trial
A Single-Center, Randomized, Double-Blind, Placebo-Controlled Single Ascending Dose and Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics Profile of Aom0319 in Healthy White SubjectsStatus: Recruiting, Estimated PCD: 2023-12-01
Abstract
ANTI-CD74 ANTIBODIES AS DIAGNOSTIC BIOMARKER FOR EARLY AXIAL SPONDYLOARTHRITIS: DATA FROM THE SPONDYLOARTHRITIS CAUGHT EARLY (SPACE) COHORT STUDY Org: Amckaus, MHH, Diakonhjemmet Hospital, UniPD, LUMC Leids Universitair Medisch Centrum,